Atlas Trials

ErbB2 Positive Metastatic Breast Cancer

Clinical trial NCT01658358 · TERMINATED

Trial details

NCT number
NCT01658358
Sponsor
China Medical University Hospital
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2012-07-01
Primary completion
2014-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.